Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Human bronchial epithelial cells from patients with asthma have an altered gene expression profile

Sangita Bhaker, Michael A. Portelli, Kamini Rakkar, Dominick Shaw, Simon Johnson, Christopher Brightling, Ian Sayers
ERJ Open Research 2022 8: 00625-2021; DOI: 10.1183/23120541.00625-2021
Sangita Bhaker
1Translational Medical Sciences, NIHR Respiratory Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK
4These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Portelli
1Translational Medical Sciences, NIHR Respiratory Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK
4These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael A. Portelli
  • For correspondence: michael.portelli@nottingham.ac.uk
Kamini Rakkar
1Translational Medical Sciences, NIHR Respiratory Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK
4These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominick Shaw
1Translational Medical Sciences, NIHR Respiratory Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dominick Shaw
Simon Johnson
1Translational Medical Sciences, NIHR Respiratory Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon Johnson
Christopher Brightling
2University of Leicester, Leicester, UK
3Dept of Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Sayers
1Translational Medical Sciences, NIHR Respiratory Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Gene changes observed in asthma bronchial epithelial cells are maintained following repeated culture, presenting with an exaggerated response to viral infection and immune responses as well as having differences in the rate of cell division and replication https://bit.ly/3Cq2xKf

To the Editor:

Asthma is a multifactorial disease presenting with wheeze and shortness of breath, and is known to be exacerbated by triggers such as pollen, house dust mites and viral infection. In the lung, the bronchial epithelium is recognised as a central driver of airway structural changes, including epithelial goblet cell hyperplasia and metaplasia, which are features of asthma. Bronchial epithelial cells (BECs) isolated from patients with asthma and cultured in vitro have altered barrier properties [1], elevated expression of remodelling factors [2] and defective repair [3]. Interestingly, genome-wide association studies (GWAS) of asthma have implicated a number of genes that are known to be expressed and functional in the airway epithelium, including IL33, IL1RL1, TSLP and MUC5AC [4]. To identify the molecular mechanisms underlying altered BECs phenotype in asthma patients, several studies have completed transcriptomic analyses using bronchial brush samples. Two recent meta-analyses [5, 6] suggested that alterations in chemical stimulus, extracellular region, pathways in cancer and arachidonic acid metabolism were features of the bronchial epithelium in the lungs of patients with asthma, and included 78 up- and 75 down-regulated genes [5]. While useful, a key question is how much the airway environment of a patient is driving this differential gene expression profile (GEP) and how much is intrinsic to the BECs themselves? To answer this question, we completed transcriptomic analyses of BECs cultured two-dimensionally through multiple passages in the laboratory that had originally been isolated from control subjects without disease or patients with asthma. An attrition rate (for successful culture) of 54% and 42% was observed in the asthma and control populations respectively.

BECs derived from bronchoscopic bronchial brushes of moderate to severe asthma subjects, as defined by British Thoracic Society guidelines, (n=33) were compared to those from non-asthma control subjects (n=18). The asthma group was predominantly female (64.7%) with a mean average age of 54 years (range 19–64 years) and mean forced expiratory volume in 1s (FEV1) of 81.9±17.6% of predicted, while the control group was predominantly male (75%), with an average age of 39 years (range 20–64 years) and a mean FEV1 of 101.5±9.55% predicted. Cells were expanded in two-dimensional culture to passage 3, as previously described [7]. RNA was collected from this cellular monolayer and transcriptomic changes determined through RNA sequencing. Briefly, sequence libraries were generated using TruSeq RNA sample preparation kits (Illumina) via the Sciclone NGS Liquid Handler (Perkin Elmer). These libraries were sequenced on an Illumina HiSeq2500 (Paired End 2×100 bp) in pools of multiple samples. The resulting read depth ranged from 10 361 312 to 19 395 273 paired-end reads. Resultant data were then processed using the Scythe/Sickle, Bowtie2 and TopHat software packages. Differential gene counts were determined using the Cufflinks software package (CuffDiff). Pathway analysis was carried out using DAVID 6.8, analysing all genes returning with a p-value of <0.05.

We identified a total of 40 differentially expressed genes (5% false discovery rate (FDR)), of which 23 were upregulated in cells from asthma patients when compared to cells obtained from control subjects (figure 1). Mining of human gene–disease associations (GDAs) using the online DisGeNET platform [8] confirmed that a number of these differentially expressed genes have previous GDAs to asthma (CEACAM5/6, COL5A1, CXCL5, DDR1, DISP2, GAS5, NOS1, THBD and TJP1) or lung function testing (SNRPN). Interestingly, other genes, i.e. CXCL5, DCR1, IFITM1 and SNRPN, were also associated to viral infections, which are recognised drivers of asthma exacerbation [9]. We also cross referenced 382 asthma GWAS genes, as defined by the search “Asthma” in GWAS Catalog (https://www.ebi.ac.uk/gwas/) and identified that COL15A1 is differentially expressed based on a Bonferroni corrected p-value of <1.3×10−4.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

RNA sequencing of primary bronchial epithelial cells taken from 33 moderate–severe asthma patients and 18 control subjects, and cultured in vitro, identifies a) modest differences in gene expression between cases and controls, that may be in part due to b) the high heterogeneity observed in our sample population. Of the transcriptomic signature of 40 differentially expressed genes meeting a 5% false discovery rate, 17 upregulated and 23 downregulated genes were identified as unique to asthma cells.

These initial analyses demonstrate that cultured BECs originally isolated from asthma patients have an altered GEP in vitro. Pathway analysis using DAVID 6.8 identified enrichment of multiple pathways in cells from asthma patients, that are broadly grouped into: 1) antiviral responses, specifically type-1 interferon responses (FDR 1.02×10−10); 2) interferon-α/β signalling (FDR 1.34×10−9); 3) immune responses (FDR 5.64×10−5); and 4) cellular division and proliferation (FDR 8.0×10−9).

Importantly, we observed minimal overlap between the gene signatures observed in this study using cultured cells with reported differential gene expression in the bronchial epithelium in the lungs of patients with asthma [5, 6]. Considering an adjusted p-value of <3.0×10−4, based on comparisons to 150 published genes, we observed that CEACAM5, encoding a cell adhesion protein that may regulate cell differentiation, apoptosis and polarity, and IL1RL1, encoding the interleukin-33 receptor that is involved in type-2 inflammation, achieved significance in both our and the published studies. Several other published genes (MMP1, DAPK1, APOC1, ACKR3, AKAP12, PTGS1, SPOCK3 and VNN1) [5], and FDFR1, KYNU, FAM83D and MCAM [6]), were observed using a nominal p-value cut-off of <0.05 in our study but did not achieve the adjusted p<3.0×10−4. These data suggest that while differential GEPs observed in vivo are at least part driven by the airway environment, certain transcriptomic changes are intrinsic, as highlighted by the presence of an altered GEPs in asthma BECs cultured independently of the airway environment.

To our knowledge, we show for the first time that the transcriptomic profile of cultured BECs isolated from patients with asthma is crucially different from those from nonasthma subjects, and that these changes not only confirm a subset of differences identified in vivo, but also identify additional new findings. These observed differences suggest that epithelial cells originating from asthma patients present with an exaggerated response to viral infection and immune responses, as well as having differences in the rate of cell division and replication. Although in general, in vitro epithelial responses are different from those observed in vivo, the few that do replicate relate well to both known morphological changes that occur in the bronchial epithelium in asthma, where epithelial cell hyperplasia is a known process occurring during airway remodelling and to altered response to infection by respiratory viruses [10]. These novel data provide greater insight into altered epithelial mechanisms in asthma and provide new understanding and potential targets for future work.

Footnotes

  • Provenance: Submitted article, peer reviewed.

  • Conflict of interest: S. Bhaker has nothing to disclose.

  • Conflict of interest: M.A. Portelli has nothing to disclose.

  • Conflict of interest: K. Rakkar has nothing to disclose.

  • Conflict of interest: D. Shaw has nothing to disclose.

  • Conflict of interest: S. Johnson has nothing to disclose.

  • Conflict of interest: C. Brightling has nothing to disclose.

  • Conflict of interest: I. Sayers reports research grants not related to the current research from GlaxoSmithKline plc and Boehringer Ingelheim.

  • Support statement: This work was supported by grants from Asthma UK (08/017 and 10/006), the Medical Research Council (G1100163), Nottingham Hospitals Charity Research Fund, the Nottingham National Institute for Health Research (NIHR) Biomedical Research Centre and the Leicester NIHR Biomedical Research Centre.

  • Received November 4, 2021.
  • Accepted November 10, 2021.
  • Copyright ©The authors 2022
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

References

  1. ↵
    1. Xiao C,
    2. Puddicombe SM,
    3. Field S, et al.
    Defective epithelial barrier function in asthma. J Allergy Clin Immunol 2011; 128: 549–556. doi:10.1016/j.jaci.2011.05.038
    OpenUrlCrossRefPubMed
  2. ↵
    1. Lopez-Guisa JM,
    2. Powers C,
    3. File D, et al.
    Airway epithelial cells from asthmatic children differentially express proremodeling factors. J Allergy Clin Immunol 2012; 129: 990–997. doi:10.1016/j.jaci.2011.11.035
    OpenUrlCrossRefPubMed
  3. ↵
    1. Kicic A,
    2. Hallstrand TS,
    3. Sutanto EN, et al.
    Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. Am J Respir Crit Care Med 2010; 181: 889–898. doi:10.1164/rccm.200907-1071OC
    OpenUrlCrossRefPubMed
  4. ↵
    1. Shrine N,
    2. Portelli MA,
    3. John C, et al.
    Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study. Lancet Respir Med 2019; 7: 20–34. doi:10.1016/S2213-2600(18)30389-8
    OpenUrl
  5. ↵
    1. Nie X,
    2. Wei J,
    3. Hao Y, et al.
    Consistent biomarkers and related pathogenesis underlying asthma revealed by systems biology approach. Int J Mol Sci 2019; 20: 4037. doi:10.3390/ijms20164037
    OpenUrl
  6. ↵
    1. Loffredo LF,
    2. Abdala-Valencia H,
    3. Anekalla KR, et al.
    Beyond epithelial-to-mesenchymal transition: common suppression of differentiation programs underlies epithelial barrier dysfunction in mild, moderate, and severe asthma. Allergy 2017; 72: 1988–2004. doi:10.1111/all.13222
    OpenUrl
  7. ↵
    1. Slater M,
    2. Torr E,
    3. Harrison T, et al.
    The differential effects of azithromycin on the airway epithelium in vitro and in vivo. Physiol Rep 2016; 4: e12960. doi:10.14814/phy2.12960
  8. ↵
    1. Pinero J,
    2. Ramirez-Anguita JM,
    3. Sauch-Pitarch J, et al.
    The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 2020; 48: D845–D855.
    OpenUrl
  9. ↵
    1. Beale J,
    2. Jayaraman A,
    3. Jackson DJ, et al.
    Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med 2014; 6: 256ra134. doi:10.1126/scitranslmed.3009124
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. James KM,
    2. Peebles RS Jr,
    3. Hartert TV
    . Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol 2012; 130: 343–351. doi:10.1016/j.jaci.2012.05.056
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Vol 8 Issue 1 Table of Contents
ERJ Open Research: 8 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Human bronchial epithelial cells from patients with asthma have an altered gene expression profile
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Human bronchial epithelial cells from patients with asthma have an altered gene expression profile
Sangita Bhaker, Michael A. Portelli, Kamini Rakkar, Dominick Shaw, Simon Johnson, Christopher Brightling, Ian Sayers
ERJ Open Research Jan 2022, 8 (1) 00625-2021; DOI: 10.1183/23120541.00625-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Human bronchial epithelial cells from patients with asthma have an altered gene expression profile
Sangita Bhaker, Michael A. Portelli, Kamini Rakkar, Dominick Shaw, Simon Johnson, Christopher Brightling, Ian Sayers
ERJ Open Research Jan 2022, 8 (1) 00625-2021; DOI: 10.1183/23120541.00625-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Asthma and allergy
  • Genetics
  • Lung biology and experimental studies
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Broadening the scope for three dimensional (3D) printed airway stents
  • Tracheal complications of mechanical ventilation for COVID-19: a plot twist for survivors
  • Diffuse panniculitis in a teen male with ZZ alpha1-antitrypsin deficiency
Show more Research letter

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society